![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Daiichi Sankyo Chemical Pharma Co., Ltd. Kanagawa Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Levodopa, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-091 - Rev 03
This Chemical Type CEP, issued on May 14, 2008, remains in force until August 30, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 38 associated with this CEP further emphasizes